- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04230135
Cultural Adaptation of Hap-pas-Hapi (Step-by-Step) for Albanian-speaking Immigrants in Switzerland and Germany
May 17, 2022 updated by: University of Zurich
Randomised Controlled Trial to Test to What Extent the Adaptation of a Smartphone-based Self-help Programme to Albanian Immigrants' Cultural Concepts of Distress Enhances Its Acceptability and Efficacy
We aim to compare two different levels of cultural adaptation of an Internet- and mobile-based intervention for the treatment of depression called Hap-pas-Hapi among Albanian-speaking immigrants in Switzerland and Germany.
One arm will include the generic (minimally adapted) version of Hap-pas Hapi.
The other arm will include a version of Hap-pas-Hapi that was adapted to the target population's cultural concepts of distress.
Both versions include five sessions and the same therapeutic techniques.
Study Overview
Study Type
Interventional
Enrollment (Actual)
97
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany
- Freie Universität Berlin
-
-
-
-
-
Zurich, Switzerland, 8050
- University of Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Electronic informed consent documented by time-stamped agreement to a set of consent questions
- Albanian-speaking
- Male and female participants aged above 18
- Kessler Psychological Distress Scale (K10), Albanian version score >15
- Access to Smartphone (iOS or Android) or web-browser
Exclusion Criteria:
- People living outside Germany or Switzerland
- Serious suicidal thoughts or plan (self-assessed with a corresponding question)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Generic (surface adaptation)
The generic version of Hap-pas-Hapi includes only surface adaptations (i.e., adaptation of text and illustrations that are inacceptable or non-meaningful for the target group)
|
Hap-pas-Hapi is a Smartphone-based intervention for the treatment of psychological distress.
It includes five sessions and uses a narrative approach.
Behavioural activation is the main active therapeutic agent in the intervention, along with stress management, positive self-talk, mood tracking, social support, and relapse prevention.
|
|
EXPERIMENTAL: Adapted (deep structure adaptation)
For the experimental intervention, Hap-pas-Hapi was adapted to Albanian immigrants' cultural concepts of distress (CCD).
An ethnopsychological study was conducted for this purpose, since evidence on CCD in South Eastern Europe is scarce.
Based on this study, three deep-structure adaptations were done: i) the symptom narrative provided by the narrator in the app was re-written to reflect Albanian immigrants' CCD; ii) a new explanatory model builder was implemented to address the target group's fatalistic beliefs; and iii) a goal-setting task was programmed to address the target group's socio-centric notion of the self.
|
Hap-pas-Hapi is a Smartphone-based intervention for the treatment of psychological distress.
It includes five sessions and uses a narrative approach.
Behavioural activation is the main active therapeutic agent in the intervention, along with stress management, positive self-talk, mood tracking, social support, and relapse prevention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological distress
Time Frame: Six weeks
|
Hopkins Symptom Checklist-25 (HSCL-25)
|
Six weeks
|
|
Treatment adherence
Time Frame: Six weeks
|
Completing at least three (out of five) sessions of Hap-pas-Hapi;
|
Six weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional impairment (health and disability)
Time Frame: Six weeks
|
WHO Disability Assessment Schedule (WHODAS 2.0)
|
Six weeks
|
|
Well-being
Time Frame: Six weeks
|
The WHO Wellbeing Index (WHO-5)
|
Six weeks
|
|
Post-traumatic stress disorder
Time Frame: Six weeks
|
The PTSD checklist, 8 items version (PCL-8)
|
Six weeks
|
|
Self-defined problems
Time Frame: Six weeks
|
The Psychological Outcome Profiles (PSYCHLOPS)
|
Six weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 15, 2020
Primary Completion (ACTUAL)
August 31, 2021
Study Completion (ACTUAL)
November 30, 2021
Study Registration Dates
First Submitted
January 13, 2020
First Submitted That Met QC Criteria
January 13, 2020
First Posted (ACTUAL)
January 18, 2020
Study Record Updates
Last Update Posted (ACTUAL)
May 25, 2022
Last Update Submitted That Met QC Criteria
May 17, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- Hap-pas-Hapi
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Distress
-
Universita di VeronaUniversity of Roma La SapienzaRecruitingDistress, Emotional | Distress, PsychologicalItaly
-
Utah State UniversityCompletedPsychological Distress | Psychological Flexibility | Psychological Well-BeingUnited States
-
Universidad de las Americas - QuitoRecruitingPsychological DistressEcuador
-
Barbel KnauperNot yet recruitingPsychological DistressCanada
-
Fondation Santé des Étudiants de FranceRecruitingPsychological DistressFrance
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedPsychological DistressItaly
-
Azienda Unita Sanitaria Locale di PiacenzaUniversity of Siena, ItalyCompleted
-
International Islamic University MalaysiaCompletedPsychological DistressSingapore
-
George Washington UniversityWorld Health Organization; Transcultural Psychosocial Organization Nepal; Socios... and other collaboratorsCompletedPsychological DistressNepal, Peru, Uganda
-
University of LincolnLincolnshire Partnership NHS Foundation TrustCompletedPsychological DistressUnited Kingdom
Clinical Trials on Hap-pas-Hapi
-
Burke Medical Research InstituteTerminated
-
VA Office of Research and DevelopmentCompleted
-
University Hospital OlomoucCompletedVentilator-Associated Pneumonia
-
National Taiwan University HospitalRecruitingDifferentiated Thyroid CancerTaiwan
-
NeurolignUniversity of Miami; Allegheny Singer Research Institute (also known as Allegheny...Not yet recruiting
-
University of MiamiCompleted
-
San Francisco Department of Public HealthCompleted
-
Binghamton UniversityLehigh University; Ascension HealthRecruitingObesity | Physical Activity | Self-efficacy | Online Intervention | AccelerometersUnited States
-
Institut National de la Santé Et de la Recherche...CompletedStroke and Healthy SubjectsFrance
-
University of MiamiSyneos Health; NeurolignWithdrawnBrain Injuries, Traumatic